Search Results

Schwannoma of the Appendix Mimicking a Metastatic Breast Cancer: A case report.

• Authors : Al-Ishaq, Zaid¹ ; Al-Sulaimani, Alonood²; Al-Qassabi, Badriya S.³

Subjects: *Metastatic breast cancer; *Breast cancer; *Cancer patientsOman

• Source: Sultan Qaboos University Medical Journal. 2025, Vol. 25 Issue 1, p132-136. 5p.

Record details

Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer.

• Authors : Feng, Mengya¹ (AUTHOR) ; Bi, Pingping² (AUTHOR) ; Kang, Yihua³ (AUTHOR)

• Source: Cancer Cell International. 12/19/2024, Vol. 24 Issue 1, p1-21. 21p.

Record details

Timing of Dose Reductions and Survival Outcomes in Metastatic Breast Cancer Patients Treated with Cyclin-Dependent Kinase 4/6 Inhibitors †.

• Authors : Kubilay Tolunay, Pınar¹ (AUTHOR) ; Kurt İnci, Bediz² (AUTHOR) ; Usta, Şura² (AUTHOR)

• Source: Current Oncology. Dec2024, Vol. 31 Issue 12, p7426-7436. 11p.

Record details

Inetetamab combined with sirolimus and chemotherapy for the treatment of HER2‐positive metastatic breast cancer patients with abnormal activation of the PI3K/Akt/mTOR pathway after trastuzumab treatment.

• Authors : Li, Qiao¹ (AUTHOR); Lv, Dan¹ (AUTHOR); Sun, Xiaoying² (AUTHOR)

• Source: Cancer Innovation. Oct2024, Vol. 3 Issue 5, p1-10. 10p.

Record details

Real-World Quality-of-Life Data in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors Using Four Assessment Tools.

• Authors : Stanciu, Ioana-Miruna^1,2 (AUTHOR) ; Nitipir, Cornelia^1,2,3 (AUTHOR)

• Source: Cancers. Mar2025, Vol. 17 Issue 5, p818. 23p.

Record details

Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations.

• Authors : Ciccioli, Mariacristina¹ (AUTHOR) ; Kim, Kyukwang² (AUTHOR); Khazan, Negar² (AUTHOR)

• Source: Journal of Experimental & Clinical Cancer Research (17569966). 8/21/2024, Vol. 43 Issue 1, p1-20. 20p.

Record details

Statistical analysis plan for the PRO B study: open-label, superiority randomised controlled trial of alarm-based patient-reported outcome monitoring in patients with metastatic breast cancer.

• Authors : Gebert, Pimrapat^1,2 (AUTHOR) ; Karsten, Maria Margarete³ (AUTHOR); Hage, Anna Maria³ (AUTHOR)

• Source: Trials. 3/6/2024, Vol. 25 Issue 1, p1-9. 9p.

Record details

Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.

• Authors : Canino, Fabio^1,2 (AUTHOR) ; Tornincasa, Antonio³ (AUTHOR) ; Bettelli, Stefania⁴ (AUTHOR)

• Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2490. 14p.

Record details

Toxicity Profiles of Antibody–Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer.

• Authors : Collineau, Bérénice¹ (AUTHOR); Gonçalves, Anthony^1,2,3 (AUTHOR); Domon, Marie^3,4 (AUTHOR)

• Source: Cancers. Jul2025, Vol. 17 Issue 14, p2307. 12p.

Record details

Efficacy of Metastasis-Directed Radiation Therapy to Prolong Systemic Therapy for Patients with Oligoprogressive Metastatic Breast Cancer.

• Authors : LeVee, Alexis¹ (AUTHOR); Young, Hannah^1,2 (AUTHOR); Yoon, Stephanie^1,2 (AUTHOR)

• Source: Cancers. Jul2025, Vol. 17 Issue 13, p2153. 14p.

Record details